Close
FINDING CURES TOGETHER<sup>SM</sup>

Use of Nivolumab Expanded to Sixth Cancer Type

Cancer Research Catalyst discusses the FDA's recent approval of the immunotherapeutic nivolumab (Opdivo) to include the treatment of certain patients with bladder cancer.

AACR in the News

Mammogram Results Can Be Misleading

The New York Times reports on a study published in the AACR journal Cancer Epidemiology, Biomarkers & Prevention.